Robert Downey Jr to play Doctor DolittlePor Fresco Pimienta Mar 20, 2017
Universal are the ones with the rights to the flick and while we don't have any plot details just yet, Gaghan and Downey Jr. are certainly an exciting pair, even if this project does seem a bit out of the ordinary for both of them.
The new movie is titled The Voyage of Doctor Dolittle and is "based on the character from the 1920's series of children's books by Hugh Lofting", according to THR. Stephen Gaghan (Syriana) is on tap to direct and will use his own screenplay.
This is the third version of Doctor Dolittle made by Hollywood.
Joe Roth and Jeff Kirschenbaum will produce for their Roth/Kirschenbaum Films alongside Susan Downey for Team Downey.
A physician who can talk to animals, the character of Doctor Dolittle first appeared on the screen in a 1967 musical directed by Richard Fleischer. The movie was nominated for the Best Picture Oscar and took home awards for Best Original Song and Best Visual Effects. His films have tended to be more grounded and serious, so unless Dolittle stumbles upon a dying elephant begging for the sweet release of death after being attacked by poachers, this will probably be a change of pace for the filmmaker.
Downey was most recently seen as Tony Stark in Captain America: Civil War and Avengers: Age of Ultron. He will reprise the role in the upcoming Spider-Man: Homecoming and Avengers: Infinity War.
CAA packaged the deal and represents Gaghan, Downey, and Roth/Kirschenbaum. Additionally, Gaghan and Downey are repped by Hansen, Jacobson, Teller, Hoberman, Newman, Warren, Richman, Rush & Kaller; and Roth/Kirschenbaum by Ziffren Brittenham.
También te puede interesar...
Investor's Watch List: Cousins Properties Incorporated (CUZ), Vista Outdoor Inc. (VSTO)
Mar 20, 2017
The stock is now moving above its 20-Day Simple Moving Average of -2.9% with the 50-Day Simple Moving Average of -2.9 percent. It is widely believed that the more practical proxy for the market's expectations is analyst's consensus price estimates.
Overview of Stock Trend: EXACT Sciences Corporation (NASDAQ:EXAS)
Mar 20, 2017
The last close places the company's stock about $0.08 off its 52 week high of $0.76 and $0.4 above the 52 week low of $0.28. Following the transaction, the insider now owns 817,239 shares in the company, valued at approximately $17,292,777.24.
Alaska Communications Announces $10 Million Share Repurchase Program Authorization
Mar 20, 2017
KS now owns 65,000 shares of the company's stock valued at $112,000 after buying an additional 10,000 shares in the last quarter. Alaska Communications (NASDAQ:ALSK) has jumped 4.3% after beating sales and profit expectations in Q4 results this morning.